19-7631479-G-T

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_StrongPM2

The NM_001171155.2(PET100):​c.145G>T​(p.Glu49*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

PET100
NM_001171155.2 stop_gained

Scores

5
2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 5.49

Publications

0 publications found
Variant links:
Genes affected
PET100 (HGNC:40038): (PET100 cytochrome c oxidase chaperone) Mitochondrial complex IV, or cytochrome c oxidase, is a large transmembrane protein complex that is part of the respiratory electron transport chain of mitochondria. The small protein encoded by this gene plays a role in the biogenesis of mitochondrial complex IV. This protein localizes to the inner mitochondrial membrane and is exposed to the intermembrane space. Mutations in this gene are associated with mitochondrial complex IV deficiency. This gene has a pseudogene on chromosome 3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]
STXBP2 (HGNC:11445): (syntaxin binding protein 2) This gene encodes a member of the STXBP/unc-18/SEC1 family. The encoded protein is involved in intracellular trafficking, control of SNARE (soluble NSF attachment protein receptor) complex assembly, and the release of cytotoxic granules by natural killer cells. Mutations in this gene are associated with familial hemophagocytic lymphohistiocytosis. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2013]
PCP2 (HGNC:30209): (Purkinje cell protein 2) Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of catalytic activity. Predicted to act upstream of or within rhodopsin mediated signaling pathway. Predicted to be located in neuronal cell body. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001171155.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.347 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001171155.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PET100
NM_001171155.2
MANE Select
c.145G>Tp.Glu49*
stop_gained
Exon 4 of 4NP_001164626.1P0DJ07
STXBP2
NM_001414484.1
c.-60+633G>T
intron
N/ANP_001401413.1
PET100
NR_033242.2
n.276G>T
non_coding_transcript_exon
Exon 5 of 5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PET100
ENST00000594797.6
TSL:1 MANE Select
c.145G>Tp.Glu49*
stop_gained
Exon 4 of 4ENSP00000470539.1P0DJ07
ENSG00000268400
ENST00000698368.1
n.114+820G>T
intron
N/AENSP00000513686.1A0A8V8TM65
PET100
ENST00000923271.1
c.184G>Tp.Glu62*
stop_gained
Exon 4 of 4ENSP00000593330.1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1384084
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
682972
African (AFR)
AF:
0.00
AC:
0
AN:
31570
American (AMR)
AF:
0.00
AC:
0
AN:
35660
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25150
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35692
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79178
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34840
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5472
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1078670
Other (OTH)
AF:
0.00
AC:
0
AN:
57852
GnomAD4 genome
Cov.:
31

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.60
D
BayesDel_noAF
Pathogenic
0.59
CADD
Pathogenic
41
DANN
Uncertain
1.0
Eigen
Pathogenic
0.83
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Pathogenic
0.98
D
PhyloP100
5.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.9
Mutation Taster
=15/185
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.31
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.31
Position offset: -6

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

hg19: chr19-7696365;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.